共 39 条
[1]
Begley D.J., Brightman M.W., Structural and functional aspects of the blood-brain barrier, Prog Drug Res, 61, pp. 39-78, (2003)
[2]
Pardridge W.M., Buciak J.L., Friden P.M., Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo, J Pharmacol Exp Ther, 259, pp. 66-70, (1991)
[3]
Yu Y.J., Zhang Y., Kenrick M., Hoyte K., Luk W., Lu Y., Atwal J., Elliott J.M., Prabhu S., Watts R.J., Dennis M.S., Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target, Sci Transl Med, 3, (2011)
[4]
Coloma M.J., Lee H.J., Kurihara A., Landaw E.M., Boado R.J., Morrison S.L., Pardridge W.M., Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor, Pharm Res, 17, pp. 266-274, (2000)
[5]
Boado R.J., Hui E.K., Lu J.Z., Zhou Q.H., Pardridge W.M., Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein, J Biotechnol, 146, pp. 84-91, (2010)
[6]
Demeule M., Currie J.C., Bertrand Y., Che C., Nguyen T., Regina A., Gabathuler R., Castaigne J.P., Beliveau R., Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2, J Neurochem, 106, pp. 1534-1544, (2008)
[7]
Gabathuler R., Development of new peptide vectors for the transport of therapeutic across the blood-brain barrier, Ther Deliv, 1, pp. 571-586, (2010)
[8]
Ohshima-Hosoyama S., Hosoyama T., Nelon L.D., Keller C., IGF-1 receptor inhibition by picropodophyllin in medulloblastoma, Biochem Biophys Res Commun, 399, pp. 727-732, (2010)
[9]
Yang C., Robbins P.D., The roles of tumor-derived exosomes in cancer pathogenesis, Clin Dev Immunol, 2011, (2011)
[10]
Thery C., Exosomes: secreted vesicles and intercellular communications, F1000 Biol Rep, 3, (2011)